Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Other Non-Current Liabilities (2016 - 2025)

Haemonetics has reported Other Non-Current Liabilities over the past 16 years, most recently at $63.6 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $63.6 million for Q4 2025, down 29.3% from a year ago — trailing twelve months through Dec 2025 was $63.6 million (down 29.3% YoY), and the annual figure for FY2025 was $68.2 million, down 9.12%.
  • Other Non-Current Liabilities for Q4 2025 was $63.6 million at Haemonetics, down from $66.1 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for HAE hit a ceiling of $100.3 million in Q2 2021 and a floor of $63.6 million in Q4 2025.
  • Median Other Non-Current Liabilities over the past 5 years was $77.2 million (2022), compared with a mean of $79.6 million.
  • Biggest five-year swings in Other Non-Current Liabilities: rose 28.71% in 2024 and later fell 29.3% in 2025.
  • Haemonetics' Other Non-Current Liabilities stood at $91.9 million in 2021, then fell by 14.85% to $78.2 million in 2022, then dropped by 2.51% to $76.3 million in 2023, then grew by 17.97% to $90.0 million in 2024, then fell by 29.3% to $63.6 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $63.6 million (Q4 2025), $66.1 million (Q3 2025), and $68.1 million (Q2 2025) per Business Quant data.